Roche

Roche’s $4.3 billion takeover offer for Spark extended till 1 October

05 Sep 2019

Roche to acquire US biotech firm Ignyta for $1.7 billion

22 Dec 2017

Roche weighs options for struggling diabetes-care business, including a sale

01 Feb 2017

Natco gets USFDA approval for generic version of Roche’s influenza drug Tamiflu

06 Aug 2016

Roche's blood cancer drug Gazyva trials show no significant improvements over older drug

18 Jul 2016

Novartis to sell stake in Roche worth $13.8 bn

25 Apr 2016

Roche in talks to buy gene sequencing systems maker Pacific Biosciences of California

03 Feb 2016

Gujarat, Telangana freeze use of Roche’s Avastin after 15 develop eye problems

20 Jan 2016

Roche to buy US biotech group Adheron Therapeutics in a $580 mn deal

10 Oct 2015

Roche to buy GeneWEAVE BioSciences

14 Aug 2015

View details about the software product Informachine News Trackers

Latest articles

Sterling pauses after four-week rally as investors assess Iran sanctions

 Sterling pauses after four-week rally as investors assess Iran sanctions

India plans first tokenised bond issue in September with REC pilot

 India plans first tokenised bond issue in September with REC pilot

Europe’s e-waste could boost critical raw material supply

 Europe’s e-waste could boost critical raw material supply

US LNG exports face endurance test as high gas prices bite

 US LNG exports face endurance test as high gas prices bite

Xiaomi launches new Xring chip, deepening push into in-house processors

 Xiaomi launches new Xring chip, deepening push into in-house processors

UP-Japan investment meet targets green hydrogen and semiconductors

 UP-Japan investment meet targets green hydrogen and semiconductors

China’s Chery to open UK R&D centre as sales surge

 China’s Chery to open UK R&D centre as sales surge

Andhra minister rejects concerns over Vizag data centres’ water use

 Andhra minister rejects concerns over Vizag data centres’ water use

AI concentration, bullish positioning and the yen intervention puzzle

 AI concentration, bullish positioning and the yen intervention puzzle